Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Suluotong
- Development stage
- Unknown
- Lead developer
- Stainwei
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Ophthalmic
01
Overview
Suluotong (STW-002) is a recombinant humanized monoclonal antibody developed by Suzhou Stainwei Biotechnology for the treatment of ophthalmic diseases, primarily neovascular age-related macular degeneration (nAMD). The drug acts as an antagonist of vascular endothelial growth factor A (VEGF-A), a key protein that promotes the growth of abnormal, leaky blood vessels in the retina. By binding to and neutralizing VEGF-A, Suluotong inhibits angiogenesis and reduces macular edema, thereby preventing vision loss and potentially improving visual acuity in patients. It is administered via intravitreal injection and is currently in clinical development for nAMD and other retinal vascular disorders such as diabetic macular edema.
- Brand names
- Suluotong
- Other names
- 速络通
02
Targets
Beyond the preview
Go deeper on Suluotong.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Suluotong.